Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akanda Corp. (AKAN) vs Neptune Wellness Solutions Inc. (NEPTF)

Akanda Corp. and Neptune Wellness Solutions Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. is the larger, with a market value of $2.4M against $1.6M — 1.5× the size. Across the 8 metrics below, Akanda Corp. leads on 6 and Neptune Wellness Solutions Inc. on 2.

Valuation

Metric AKAN NEPTF Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S n/m n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 1.06 2.56
Earnings yield — 0.00% (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric AKAN NEPTF Drug Manufacturers Specialty & Generic median
Gross margin — (1.94%) 53.94%
Operating margin — (190.39%) 0.00%
Net margin — (135.24%) 0.00%
Free cash flow margin 0.00% (40.57%) 0.00%
Return on equity 0.00% 291.47% (0.40%)
Return on assets 0.00% (121.62%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN NEPTF Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (24.78%) 10.01%
EPS growth (last fiscal year) (139.63%) 67.05% —
Revenue growth, 5-year CAGR 44.20% 19.52% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN NEPTF Drug Manufacturers Specialty & Generic median
Debt to equity (1.08) (0.50) 0.05
Current ratio 0.58 0.23 2.31
Net debt to EBITDA (2.75) (0.21) 0.85

Dividend

Metric AKAN NEPTF Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKAN NEPTF Drug Manufacturers Specialty & Generic median
Market cap 2.44m 1.60m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack